Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Underutilization of Pharmacists
07/13/2022
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this...
07/13/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Class Action Lawsuit Filed Against Pharmacy Due to Data Breach
07/12/2022
In this commentary, Ann Latner reviews legal proceedings surrounding a months-long data breach at a Massachusetts-based pharmacy that left the personal information of 75,000 patients exposed.
In this commentary, Ann Latner reviews legal proceedings surrounding a months-long data breach at a Massachusetts-based pharmacy that left the personal information of 75,000 patients exposed.
In this commentary, Ann Latner...
07/12/2022
Pharmacy Learning Network

Advertisement

Commentary
New CMS Rule Brings Value-Based Purchasing Arrangements to State Medicaid Pharmacy Programs
07/08/2022
In this commentary, Wilson Haong, PharmD, MBA, managed care pharmacy resident, discusses details of a new CMS rule regarding value-based contracts for Medicaid programs.
In this commentary, Wilson Haong, PharmD, MBA, managed care pharmacy resident, discusses details of a new CMS rule regarding value-based contracts for Medicaid programs.
In this commentary, Wilson...
07/08/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Effective Strategies to Enhance Safety
07/06/2022
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of...
07/06/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Missouri Law Prevents Pharmacists From Disputing Ivermectin Efficacy With Physicians
07/05/2022
Ann Latner, JD, shares how the Missouri Pharmacy Association responded to a bill barring pharmacists from disputing the efficacy of ivermectin and hydroxychloroquine sulfate with physicians and patients.
Ann Latner, JD, shares how the Missouri Pharmacy Association responded to a bill barring pharmacists from disputing the efficacy of ivermectin and hydroxychloroquine sulfate with physicians and patients.
Ann Latner, JD, shares how the...
07/05/2022
Pharmacy Learning Network

Advertisement

Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Defining the Problem
06/29/2022
In the first part of this series, Dr Munger shares how adverse events impact costs, resource utilization, and outcomes in the United States.
In the first part of this series, Dr Munger shares how adverse events impact costs, resource utilization, and outcomes in the United States.
In the first part of this...
06/29/2022
Pharmacy Learning Network
Insulin test and sugar
Commentary
Understanding Metabolic Syndrome: Measures to Reduce Risk and Prevalence
06/28/2022
"Increasing awareness about the serious health consequences associated with undetected and untreated metabolic syndrome is critical as the number of individuals with obesity continues to increase," writes Yvette C Terrie, BS Pharm, RPh,...
"Increasing awareness about the serious health consequences associated with undetected and untreated metabolic syndrome is critical as the number of individuals with obesity continues to increase," writes Yvette C Terrie, BS Pharm, RPh,...
"Increasing awareness about the...
06/28/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
Overdose Deaths in the United States: What Can Pharmacists Do?
06/20/2022
Dr Munger reviews the prevalence of overdose deaths in the United States and shares how pharmacists can help improve patient access to resources and treatment.
Dr Munger reviews the prevalence of overdose deaths in the United States and shares how pharmacists can help improve patient access to resources and treatment.
Dr Munger reviews the prevalence...
06/20/2022
Pharmacy Learning Network

Advertisement

Stock image of sleeping child
Commentary
SLEEP 2022: Research Validates the Impact of Sleep Disturbances on Overall Health and Well-Being
06/14/2022
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, reviews findings from the recent SLEEP 2022 meeting and emphasizes the need to ensure patients are getting enough sleep.
Yvette C Terrie, BS Pharm, RPh, consultant pharmacist, reviews findings from the recent SLEEP 2022 meeting and emphasizes the need to ensure patients are getting enough sleep.
Yvette C Terrie, BS Pharm, RPh,...
06/14/2022
Pharmacy Learning Network
Headshot of Ann Latner, JD
Commentary
Amazon’s PillPack Online Pharmacy Settles Department of Justice Lawsuit for $6 Million
06/13/2022
PillPack admitted to improperly billing Medicare and Medicaid for more insulin pens than patients needed, writes Ann W Latner, JD.
PillPack admitted to improperly billing Medicare and Medicaid for more insulin pens than patients needed, writes Ann W Latner, JD.
PillPack admitted to improperly...
06/13/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use